Declotting of Quinton-Scribner shunts.
D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008722:Methods; D010447:Peptide Hydrolases; D006435:Renal Dialysis; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D010447:Peptide Hydrolases